-+ 0.00%
-+ 0.00%
-+ 0.00%

International Stem Cell Delays Q3 Report Over Discontinued Operations Accounting

PUBT·11/17/2026 21:02:03
International Stem Cell Delays Q3 Report Over Discontinued Operations Accounting
  • International Stem Cell delayed its Form 10-Q for the quarter ended September 30, 2026, primarily because of accounting for a business sale.
  • The third-quarter sale of Lifeline Cell Technology requires discontinued operations accounting, including recasting prior-period financial statements.
  • Filing is expected within five calendar days of the prescribed deadline.
  • No significant year-over-year change in operating results is anticipated.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. International Stem Cell Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-008910), on November 17, 2026, and is solely responsible for the information contained therein.